Showing results (111-120 of 121) with videos related to
Sort By:
Pageof 13
Endoscopy International Open|February 4, 2020
Percutaneous transhepatic biliary drainage may be the preferred preoperative drainage method in hilar cholangiocarcinomaYongjiang Ba, Ping Yue, Joseph W Leung, et al.Human Cell|January 22, 2024
Establishment and characterization of DPC-X4: a novel mixed-type ampullary cancer cell lineChangpeng Chai, Huan Tang, Jianfeng Yi, et al.Human Cell|July 16, 2024
Establishment and characterization of the PDAC-X3 cell line: a novel Chinese-origin pancreatic ductal adenocarcinoma cell lineChangpeng Chai, Huan Tang, Xin Miao, et al.Human Cell|August 17, 2025
Establishment and characterization of a new Chinese extrahepatic cholangiocarcinoma cell line, EBC-X1Yuanhui Su, Huan Tang, Xin Miao, et al.Eclinicalmedicine|January 1, 2021
The evaluation of ENGBD versus PTGBD in high-risk acute cholecystitis: A single-center prospective randomized controlled trialPeilei Mu, Yanyan Lin, Xianzhuo Zhang, et al.BMC Cancer|December 20, 2024
Establishment and characterization of a new intestinal-type ampullary carcinoma cell line, DPC-X3Changpeng Chai, Xin Miao, Yuanhui Su, et al.Eclinicalmedicine|June 16, 2022
A novel machine learning model and a public online prediction platform for prediction of post-ERCP-cholecystitis (PEC)Xu Zhang, Ping Yue, Jinduo Zhang, et al.BMC Cancer|May 28, 2026
Establishment and characterization of a novel human ampullary carcinoma cell line derived from a Chinese patientYuanhui Su, Wei Huang, Xin Miao, et al.Lancet (London, England)|May 3, 2016
Routine pre-procedural rectal indometacin versus selective post-procedural rectal indometacin to prevent pancreatitis in patients undergoing endoscopic retrograde cholangiopancreatography: a multicentre, single-blinded, randomised controlled trialHui Luo, Lina Zhao, Joseph Leung, et al.The Lancet. Gastroenterology & Hepatology|April 21, 2019
Optimal dilation time for combined small endoscopic sphincterotomy and balloon dilation for common bile duct stones: a multicentre, single-blinded, randomised controlled trialWenbo Meng, Joseph W Leung, Kai Zhang, et al.Pageof 13